David Perlmutter
Executive Vice Chancellor for Medical Affairs, Washington University · Washington Univ Sch of Med
Credentials: · · ·
History
PresentSchool of Medicine · Washington Univ Sch of Med
- Present
Pediatrics
Research
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy · 2016 · 4,439 citations
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy · 2012 · 2,918 citations
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Review · Autophagy · 2008 · 2,011 citations
29 papers
12 papers · 4 as a fellow
6 papers
5 papers · 1 as a fellow
4 papers · 4 as a resident
4 papers
4 papers
3 papers
Grants
- 2021–2026
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $2.4M · Washington University
- 2012–2024
New Therapies for Liver Fibrosis and Hyperproliferation in Alpha1-AT Deficiency
National Institute of Diabetes and Digestive and Kidney Diseases · P01
Contact PI · $18.3M · Washington University
- 2013–2018
Research Training Program for Pediatric Subspecialty Fellows
National Institute of Child Health and Human Development · T32
Contact PI · $552.2K · University of Pittsburgh at Pittsburgh
- 2014–2017
Signaling Pathways Influencing Liver Disease Phenotype in Antitrypsin Deficiency
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.8M · Washington University
Clinical trials
- 2012–2017
Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency
Principal investigator · Terminated · Phase 2
Washington University School of Medicine
- 1999
Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency
Study chair · Terminated
National Center for Research Resources (NCRR)